Amplified CCT expression in cancer cells could, therefore, directly promote cell cycling by folding essential substrates like tubulin or cdc20 and indirectly through interactions with transcription factors like MYC, and promoting the expression of cell cycling factors like cyclin D. The gene discussed is FLVCR2; the disease is cancer.